GSK1349572 First Time in Human Study
NCT00555035
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
20
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Subjects
Interventions
DRUG:
GSK1349572
Sponsor
GlaxoSmithKline